Open Rank of UNMCCC in IM Molecular Medicine - Cancer Focused Autophagy Researcher - req# 7024
Open Rank of UNMCCC in IM Molecular Medicine - Cancer Focused Autophagy Researcher
|Faculty Type||Open Rank|
|Hiring Department||Division of Molecular Medicine (099X)|
|Academic Location||School of Medicine|
|Benefits Eligible||The University of New Mexico provides a comprehensive package of benefits including medical, dental, vision, and life insurance. In addition, UNM offers educational benefits through the tuition remission and dependent education programs. See the Benefits home page for more information.|
The University of New Mexico National Cancer Institute (NCI) Designated Comprehensive Cancer Center (UNMCCC) and the University of New Mexico School of Medicine (UNM SOM) invite applications from funded scientists (open rank, but preferably established mid-career or senior investigators) engaged in studies of the regulation and roles of autophagy as it relates to cancer biology with a focused interest in basic and translational research. The successful applicant will have a rigorous research program centered on the intersection of autophagy and cancer, in areas such as microenvironmental and oxidative stress, tumor cell growth and aggressiveness, mitochondrial function, genome stability, stromal cell effects, and metabolism or immunity. Successful applicants will join a vibrant and highly collaborative research community in the UNMCCC whose research spans from fundamental discovery to translational and clinical science. Many Center members have identified novel diagnostic and therapeutic targets in breast, ovarian, and colorectal cancers and hematologic malignancies and are developing novel targeted therapies in collaboration with the UNMCCC Early Phase Clinical Trails Unit. We particularly seek scientists who would collaborate and benefit from superb, state-of-the-art core facilities in single molecule, live cell, and intra-vital imaging. Successful applicants will also benefit from collaboration with unique national centers and programs at UNM and the UNMCCC including: The Center of Biomedical Research Excellence in Autophagy, Inflammation and Metabolism (www.autophagy.center), The Molecular Discovery and High Throughput Target Screening Center (nmmlsc.health.unm.edu); one of 6 of the nation’s Chemical Biology Consortium in The NCI NExT Program; and The New Mexico Center for the Spatiotemporal Modeling of Cell Signaling (stmc.health.unm.edu), an NIGMS-funded National Center for Systems Biology. Successful applicants will have a strong track record of sustained scientific accomplishments exemplified by peer-reviewed funding (NCI, NIH, or other agencies), high quality publications, and collaborative research. Significant resources, including excellent salaries, comprehensive start-up packages, and endowed positions are available, as are UNMCCC leadership roles. Significant resources, including excellent salaries, comprehensive start-up packages, and endowed professorships and chairs are available, as are UNMCCC leadership roles. Successful candidates will have a faculty appointment in a UNM School of Medicine Department (Internal Medicine, Pathology, Molecular Genetics & Microbiology) and hold membership in the UNMCCC.
The University of New Mexico Comprehensive Cancer Center (UNMCCC) is the Official Cancer Center of New Mexico and the only National Cancer Institute (NCI) Designated Comprehensive Cancer Center in a 500-mile radius. The 134 oncology physicians, 122 cancer research scientists, and staff are particularly focused on discovering the causes and the cures for cancers that disproportionately affect the people of the American Southwest - primarily Hispanic, American Indian, and Non-Hispanic White - with strikingly different patterns of cancer incidence, mortality and disparity. The Center treated 12,000 unique patients in FY17, 12% of whom participated in therapeutic interventional studies and 35% of whom participated in interventional studies. The UNMCCC has outstanding research programs in Cancer Control and Cancer Health Disparities; Cancer Genetics, Epigenetics, and Genomics; Cancer Cell and Systems Biology; and Cancer Therapeutics. These programs house several national centers including: The Molecular Discovery and High Throughput Target Screening Center (nmmlsc.health.unm.edu), one of the nation’s 6 Chemical Biology Consortium Centers of Excellence in The NCI NExT Program; The New Mexico Center for the Spatiotemporal Modeling of Cell Signaling (stmc.health.unm.edu), one of 13 NIH National Centers for Systems Biology; and a NIH Clinical and Translational Sciences Center. Rich collaborations with UNMCCC partners (Sandia and Los Alamos National Laboratories; Lovelace Respiratory Research Institute) enrich our research endeavors. The UNMCCC is the center of a collaborative statewide cancer clinical trials and health delivery research network funded in part through a NCI NCORP Grant (Minority/Underserved) and is also a member of the ORIEN National Cancer Precision Medicine Network (http://oriencancer.org/). Learn more at http://cancer.unm.edu/
|Application Instructions||Complete applications will include a cover letter, curriculum vitae, and the names of three references with mailing address, phone numbers and email address. For all inquiries or questions, please contact:Search Chairs: Dr. Eric Prossnitz, PhD|
|For Best Consideration||For best consideration, please apply by . This position will remain open until filled.|
The University of New Mexico is committed to hiring and retaining a diverse workforce. We are an Equal Opportunity Employer, making decisions without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, veteran status, disability, or any other protected class.